Literature DB >> 10712667

An acidic microenvironment impairs the generation of non-major histocompatibility complex-restricted killer cells.

B Müller1, B Fischer, W Kreutz.   

Abstract

The microenvironment within solid tumours has often been shown to exhibit an acidic local pH. In recent studies we could demonstrate that an acidic extracellular pH (pHe) inhibits the non-major histocompatibility complex (MHC) -restricted cytotoxicity of immunocompetent effector cells. However, within tumours the activation of cytotoxic cells may already be impaired by low pHe. Therefore, we investigated the influence of acidic conditions on the generation of active killer cells. The cytotoxic activity of natural killer (NK) as well as lymphokine-activated killer (LAK) cells against K562, Daudi and Raji cells was analysed after an activation period of 3 days at pHe 7.2-6.5. A minor reduction of pHe from 7.2 to 7.0 during the culture period resulted in a strong inhibition of the natural cytotoxicity of NK cells. Furthermore, acidic pHe below 7.2 prevented the generation of activated LAK cells by interleukin-2 (IL-2). The cytotoxic capacity could not be reconstituted if cells cultured at a pHe of 6.5 were returned to physiological pH for another 24 hr. Analysis of the cellular subtypes within the various cultures did not reveal differences regarding the frequencies of NK cells, CD8+ T cells, or CD4+ T cells. However, an acidic pHe clearly inhibited the activation-induced increase of relevant adhesion molecules. The production of cytokines which are involved in the regulation of the cytotoxic process (tumour necrosis factor-alpha, interferon-gamma, IL-10, IL-12 and transforming growth factor-beta1) was also affected by pHe, as their release was strongly inhibited at pHe 7.0. Furthermore, we observed a considerable decrease in the metabolic activity of effector cells at acidic pHe. In summary, our findings suggest that an acidic microenvironment impairs the induction of an anti-tumoral immune response within solid tumours.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712667      PMCID: PMC2327168          DOI: 10.1046/j.1365-2567.2000.00975.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  39 in total

1.  An acidic microenvironment inhibits antitumoral non-major histocompatibility complex-restricted cytotoxicity: implications for cancer immunotherapy.

Authors:  B Fischer; B Müller; P Fisch; W Kreutz
Journal:  J Immunother       Date:  2000 Mar-Apr       Impact factor: 4.456

2.  Induction of calcium flux and enhancement of cytolytic activity in natural killer cells by cross-linking of the sheep erythrocyte binding protein (CD2) and the Fc-receptor (CD16).

Authors:  C Anasetti; P J Martin; C H June; K E Hellstrom; J A Ledbetter; P S Rabinovitch; Y Morishita; I Hellstrom; J A Hansen
Journal:  J Immunol       Date:  1987-09-15       Impact factor: 5.422

3.  Comparative studies of human FcRIII-positive and negative natural killer cells.

Authors:  A Nagler; L L Lanier; S Cwirla; J H Phillips
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

4.  Functional expression of CD28 on T cell antigen receptor gamma/delta-bearing T lymphocytes.

Authors:  R Testi; L L Lanier
Journal:  Eur J Immunol       Date:  1989-01       Impact factor: 5.532

Review 5.  An explanation of the variable clinical response to interleukin 2 and LAK cells.

Authors:  G Parmiani
Journal:  Immunol Today       Date:  1990-04

6.  Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1.

Authors:  T Espevik; I S Figari; G E Ranges; M A Palladino
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

7.  Cytokines alter target cell susceptibility to lysis. II. Evaluation of tumor infiltrating lymphocytes.

Authors:  H Stötter; E A Wiebke; S Tomita; A Belldegrun; S Topalian; S A Rosenberg; M T Lotze
Journal:  J Immunol       Date:  1989-03-01       Impact factor: 5.422

8.  Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells.

Authors:  J J Mulé; S L Schwarz; A B Roberts; M B Sporn; S A Rosenberg
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

9.  Involvement of CD56 (NKH-1/Leu-19 antigen) as an adhesion molecule in natural killer-target cell interaction.

Authors:  T Nitta; H Yagita; K Sato; K Okumura
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

10.  Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis.

Authors:  J H Phillips; L L Lanier
Journal:  J Exp Med       Date:  1986-09-01       Impact factor: 14.307

View more
  23 in total

1.  A bioluminescent transposon reporter-trap identifies tumor-specific microenvironment-induced promoters in Salmonella for conditional bacterial-based tumor therapy.

Authors:  Kelly Flentie; Brandon Kocher; Seth T Gammon; Deborah V Novack; Jeffrey S McKinney; David Piwnica-Worms
Journal:  Cancer Discov       Date:  2012-05-03       Impact factor: 39.397

Review 2.  Evolution of non-cytotoxic uterine natural killer cells.

Authors:  Satyan Kalkunte; Clinton O Chichester; Francesca Gotsch; Charles L Sentman; Roberto Romero; Surendra Sharma
Journal:  Am J Reprod Immunol       Date:  2008-05       Impact factor: 3.886

3.  Improving the Clinical Significance of Preclinical Immunotherapy Studies through Incorporating Tumor Microenvironment-like Conditions.

Authors:  Luke Maggs; Soldano Ferrone
Journal:  Clin Cancer Res       Date:  2020-06-22       Impact factor: 12.531

4.  Colorectal cancer extracellular acidosis decreases immune cell killing and is partially ameliorated by pH-modulating agents that modify tumor cell cytokine profiles.

Authors:  Kelsey E Huntington; Anna Louie; Lanlan Zhou; Attila A Seyhan; Aaron Wp Maxwell; Wafik S El-Deiry
Journal:  Am J Cancer Res       Date:  2022-01-15       Impact factor: 6.166

Review 5.  Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells.

Authors:  Michelle L Saetersmoen; Quirin Hammer; Bahram Valamehr; Dan S Kaufman; Karl-Johan Malmberg
Journal:  Semin Immunopathol       Date:  2018-10-25       Impact factor: 9.623

Review 6.  Molecular Connections between Cancer Cell Metabolism and the Tumor Microenvironment.

Authors:  Calvin R Justus; Edward J Sanderlin; Li V Yang
Journal:  Int J Mol Sci       Date:  2015-05-15       Impact factor: 5.923

7.  A novel model for studies of blood-mediated long-term responses to cellular transplants.

Authors:  Maria Hårdstedt; Susanne Lindblom; Jaan Hong; Bo Nilsson; Olle Korsgren; Gunnar Ronquist
Journal:  Ups J Med Sci       Date:  2014-10-17       Impact factor: 2.384

Review 8.  The Tumor Microenvironment Factors That Promote Resistance to Immune Checkpoint Blockade Therapy.

Authors:  Bonnie L Russell; Selisha A Sooklal; Sibusiso T Malindisa; Lembelani Jonathan Daka; Monde Ntwasa
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244

9.  Inhibition of host Ogr1 enhances effector CD8+ T-cell function by modulating acidic microenvironment.

Authors:  Lin Cao; Weisha Li; Xingjiu Yang; Wenlong Zhang; Mengyuan Li; Haizeng Zhang; Chuan Qin; Xiaohong Chen; Ran Gao
Journal:  Cancer Gene Ther       Date:  2021-06-22       Impact factor: 5.854

Review 10.  Acidic tumor microenvironment and pH-sensing G protein-coupled receptors.

Authors:  Calvin R Justus; Lixue Dong; Li V Yang
Journal:  Front Physiol       Date:  2013-12-05       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.